GH: Guardant Corp Company Current Liabilities

Official company branding of Guardant360 (GH)

Guardant Health, Inc. (GH) is developing its own R&D technologies without mergers, striving for leadership in liquid biopsy. However, geopolitical conflicts and sanctions are hindering the global expansion of its tests. It is critical for management to secure insurance coverage to achieve profitability. An assessment of short-term debt demonstrates a balance between equity and loans, with the metric level standing at 0.00, which determines the financial stability of the business.

GH (Guardant Health) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for Guardant Corp (GH)

- current quotes and average value forecast:
Price Chart Guardant Health|GH - Fair Value Consensus
- market capitalization information:
Market Valuation Guardant Health, Inc.|GH - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Book Value per Share Guardant Health|GH - Book Capitalization|Market Value to Book Value Ratio guardanthealth.com|GH - Total Business Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Guardant Health, Inc.|GH - Long-Term Debt to Capital|Short-Term Debt to Equity Guardant Health, Inc.|GH - Company Debts|Debt to Book Value Guardant Health, Inc.|GH - Long-Term Debt|Company Short-Term Debt Guardant Health
Fundamental company valuation:Guardant Health - GH
Manufactured products of Guardant Health, Inc.

This indicator measures the total liabilities of Guardant Health, Inc. (GH) due within one year, allowing investors to quickly assess the risk of a cash gap between reporting periods. By analyzing financial liabilities with a maturity of up to 12 months on GURU.Markets, one can confirm the liquidity stability of Guardant Health, Inc. (GH), which is supported by growing demand for liquid biopsy and the business's gradual movement toward operational break-even.

Main competitors

CAI - Company Short-Term Debt|Company Short-Term Loans and Borrowings VCYT (Veracyte Inc)|CELC (Celcuity Corp) - Company Current Liabilities|GRAIL Bio - Company Short-Term Loans and Borrowings|MYGN (Myriad Genetics, Inc.) - Company Short-Term Debts|Company Short-Term Debts castlebiosciences.com|Company Short-Term Debt Burning Rock (BNR)|volition.com - Company Short-Term Indebtedness|Company Short-Term Debts BDSX (Biodesix Corp)|Company Short-Term Debts Precipio Inc PRPO|CHEK - Company Short-Term Debt|MYNZ: Company Short-Term Debt|OCX (OncoCyte) - Company Current Liabilities